- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ascendis Pharma AS DRC (A1SN34)
Ascendis Pharma AS DRC stock price live, this page displays BVMF A1SN34 stock exchange data. View the A1SN34 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ascendis Pharma AS DRC real time stock price chart below.
What Is the Ascendis Pharma AS DRC Stock Price Today?
The Ascendis Pharma AS DRC stock price today is 95.22.
What Is the Stock Symbol for Ascendis Pharma AS DRC?
The stock symbol for Ascendis Pharma AS DRC is "A1SN34."
What Stock Exchange Does Ascendis Pharma AS DRC Trade On?
Ascendis Pharma AS DRC is listed and trades on the B3 stock exchange.
Is Ascendis Pharma AS DRC a Good Stock to Buy?
Determining whether Ascendis Pharma AS DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the A1SN34 quote. (ISIN: BRA1SNBDR008)
What Is the Ascendis Pharma AS DRC Stock Price Today?
The Ascendis Pharma AS DRC stock price today is 95.22.
What Is the Stock Symbol for Ascendis Pharma AS DRC?
The stock symbol for Ascendis Pharma AS DRC is "A1SN34."
What Stock Exchange Does Ascendis Pharma AS DRC Trade On?
Ascendis Pharma AS DRC is listed and trades on the B3 stock exchange.
Is Ascendis Pharma AS DRC a Good Stock to Buy?
Determining whether Ascendis Pharma AS DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the A1SN34 quote. (ISIN: BRA1SNBDR008)
B3
Currency in BRL
95.22
+0.81(+0.86%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
94.41
95.22
52 wk Range
70.00
95.22
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
94.4195.22
52 wk Range
70.0095.22
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
A1SN34 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
Aug 13, 2026
EPS / Forecast
2.83 / --
Revenue / Forecast
339.29M / --
Compare A1SN34 to Peers and Sector
Metrics to compare | A1SN34 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipA1SN34PeersSector | |
|---|---|---|---|---|
P/E Ratio | 20.5x | −3.1x | −0.2x | |
PEG Ratio | 0.06 | −0.11 | 0.00 | |
Price/Book | 10.6x | 1.9x | 2.6x | |
Price / LTM Sales | 14.5x | 7.9x | 2.8x | |
Upside (Analyst Target) | - | 109.1% | 60.9% | |
Fair Value Upside | Unlock | −2.3% | 9.5% | Unlock |
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Ascendis Pharma AS BDR (A1SN34) Stock Price Today?
The Ascendis Pharma AS BDR stock price today is 95.22 BRL.
What Stock Exchange Does Ascendis Pharma AS BDR Trade On?
Ascendis Pharma AS BDR is listed and trades on the B3 Stock Exchange.
What Is the Stock Symbol for Ascendis Pharma AS BDR?
The stock symbol for Ascendis Pharma AS BDR is "A1SN34."
What Is the Ascendis Pharma AS BDR Market Cap?
As of today, Ascendis Pharma AS BDR market cap is 94.07B BRL.
What Is Ascendis Pharma AS BDR's Earnings Per Share (TTM)?
The Ascendis Pharma AS BDR EPS (TTM) is 70.63.
From a Technical Analysis Perspective, Is A1SN34 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Ascendis Pharma AS BDR Stock Split?
Ascendis Pharma AS BDR has split 0 times.
How Many Employees Does Ascendis Pharma AS BDR Have?
Ascendis Pharma AS BDR has 1189 employees.
What is the current trading status of Ascendis Pharma AS BDR (A1SN34)?
As of Nov 11, 2026, Ascendis Pharma AS BDR (A1SN34) is trading at a price of 95.22 BRL, with a previous close of 95.22 BRL. The stock has fluctuated within a day range of 94.41 BRL to 95.22 BRL, while its 52-week range spans from 70.00 BRL to 95.22 BRL.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.